Se recomienda no realizar ejercicio físico vigoroso hasta que desaparezca el dolor torácico y que los marcadores de inflamación se hayan normalizado.[1]Adler Y, Charron P, Imazio M, et al; ESC Scientific Document Group. 2015 ESC guidelines for the diagnosis and management of pericardial diseases. Eur Heart J. 2015 Nov 7;36(42):2921-64.
https://academic.oup.com/eurheartj/article/36/42/2921/2293375
http://www.ncbi.nlm.nih.gov/pubmed/26320112?tool=bestpractice.com
[14]Little WC, Freeman GL. Pericardial disease. Circulation. 2006 Mar 28;113(12):1622-32.
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.105.561514
http://www.ncbi.nlm.nih.gov/pubmed/16567581?tool=bestpractice.com
[36]Imazio M, Spodick DH, Brucato A, et al. Controversial issues in the management of pericardial diseases. Circulation. 2010 Feb 23;121(7):916-28.
http://www.ncbi.nlm.nih.gov/pubmed/20177006?tool=bestpractice.com
[54]Kim JH, Baggish AL, Levine BD, et al. Clinical considerations for competitive sports participation for athletes with cardiovascular abnormalities: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2025 Mar 18;151(11):e716-61.
https://www.ahajournals.org/doi/10.1161/CIR.0000000000001297
http://www.ncbi.nlm.nih.gov/pubmed/39973614?tool=bestpractice.com
A menudo se considera adecuado un mínimo de 3 meses de restricción del ejercicio (y se recomienda para pacientes que participan en deportes competitivos), pero se pueden considerar períodos más cortos dependiendo de las características del paciente y de la enfermedad (p. ej., no deportistas y/o cuadro clínico leve).[1]Adler Y, Charron P, Imazio M, et al; ESC Scientific Document Group. 2015 ESC guidelines for the diagnosis and management of pericardial diseases. Eur Heart J. 2015 Nov 7;36(42):2921-64.
https://academic.oup.com/eurheartj/article/36/42/2921/2293375
http://www.ncbi.nlm.nih.gov/pubmed/26320112?tool=bestpractice.com
[14]Little WC, Freeman GL. Pericardial disease. Circulation. 2006 Mar 28;113(12):1622-32.
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.105.561514
http://www.ncbi.nlm.nih.gov/pubmed/16567581?tool=bestpractice.com
[36]Imazio M, Spodick DH, Brucato A, et al. Controversial issues in the management of pericardial diseases. Circulation. 2010 Feb 23;121(7):916-28.
http://www.ncbi.nlm.nih.gov/pubmed/20177006?tool=bestpractice.com
[55]Pelliccia A, Solberg EE, Papadakis M, et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2019 Jan 1;40(1):19-33.
http://www.ncbi.nlm.nih.gov/pubmed/30561613?tool=bestpractice.com
La pericarditis constrictiva excluye a los pacientes de los deportes competitivos.